Publications by authors named "A Kadner"
Primary cardiac tumors are rare, most of them being benign. Most malignant cardiac tumors are sarcomas, with the most important therapeutic option being surgery, along with perioperative chemo- and radiotherapy. Here, we present a case of a 67-year-old female patient with no prior medical condition, who presented with primary cardiac sarcoma and extensive tumor growth in the pulmonary artery.
View Article and Find Full Text PDFArticle Synopsis
- - This study assessed how well different types of arterial and venous cannulae perform in a pediatric ECMO setup under both pulsatile and non-pulsatile flow conditions.
- - The researchers found that in pulsatile flow, lower pump speeds were needed, and the flow increase in the mock circuit was less significant, while non-pulsatile conditions resulted in higher pressures and overall energy levels.
- - The conclusion suggested that non-pulsatile conditions offer better support with higher total hemodynamic energy, but pulsatile conditions are more physiological and are recommended for testing ECMO systems.
Article Synopsis
- Some doctors studied if using a special heparin-coated machine during heart surgery helped reduce bleeding and inflammation better than a regular machine.
- They looked at 49 patients who had similar backgrounds, dividing them into two groups: one used the heparin-coated machine, and the other used the regular one.
- In the end, the results showed that the heparin-coated machine didn't make a big difference in bleeding or inflammation compared to the normal one after the surgery.
Background: Heart transplantation with donation after circulatory death and ex-situ heart perfusion offers excellent outcomes and increased transplantation rates. However, improved graft evaluation techniques are required to ensure effective utilization of grafts. Therefore, we investigated circulating factors, both in-situ and ex-situ, as potential biomarkers for cardiac graft quality.
View Article and Find Full Text PDFObjectives: The use of ventricular assist devices (VADs) in children is increasing. However, absolute numbers in individual centres and countries remain small. Collaborative efforts such as the Paedi-European Registry for Patients with Mechanical Circulatory Support (EUROMACS) are therefore essential for combining international experience with paediatric VADs.
View Article and Find Full Text PDF